About Akkure
Akkure is a company based in Dublin (Ireland) founded in 2016 by Amy Hollingworth and Oran Rigby. Akkure has raised $3.37 million across 3 funding rounds from investors including Enterprise Ireland and Digital Transformation Innovation Fund. Akkure offers products and services including AI Cancer Trial Finder and Genomics Platform. Akkure operates in a competitive market with competitors including Unlearn, Virtonomy, ELEM Biotech, adsilico and Demiurge Technologies, among others.
- Headquarter Dublin, Ireland
- Founders Amy Hollingworth, Oran Rigby
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.37 M (USD)
in 3 rounds
-
Latest Funding Round
$718.06 K (USD), Grant
Nov 22, 2022
-
Investors
Enterprise Ireland
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Akkure
Akkure offers a comprehensive portfolio of products and services, including AI Cancer Trial Finder and Genomics Platform.
Tool for precise patient matching to cancer trials using AI
Platform streamlining clinical trial recruitment for hospitals
People of Akkure
Unlock access to complete
Unlock access to complete
Funding Insights of Akkure
Akkure has successfully raised a total of $3.37M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $718.06 thousand completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Akkure
Akkure has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Enterprise Ireland and Digital Transformation Innovation Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Support is provided to Irish manufacturing and service sector businesses.
|
Locked | Locked | Locked |
Investor details for Akkure
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Akkure
Investment portfolio details for Akkure
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Akkure
Detailed financials for Akkure
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Akkure Comparisons
Peer comparison for Akkure
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Akkure
Akkure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unlearn, Virtonomy, ELEM Biotech, adsilico and Demiurge Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-based clinical trial management software
|
|
| Locked | Locked | Locked |
Virtual patient simulations are provided for medical device development.
|
|
| Locked | Locked | Locked |
A simulation-based platform for virtual medical trials is provided.
|
|
| Locked | Locked | Locked |
In-silico trial solutions for medical device testing are developed.
|
|
| Locked | Locked | Locked |
Developer of neural network models and neuromorphic chips
|
Detailed competitors of Akkure
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Akkure
Complete news archive for Akkure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Akkure
Akkure was founded in 2016 and raised its 1st funding round 5 years after it was founded.
Akkure is headquartered in Dublin, Ireland.
Akkure is a funded company, having raised a total of $3.37M across 3 funding rounds to date.
Akkure was established in 2016 in Dublin, Ireland, within the genomics and blockchain sectors. An online platform is operated for handling genomic data, where user control and management of data are facilitated, including rewards for sharing. Connections are enabled between researchers and organizations for ordering DNA test kits, obtaining sequencing results, and conducting data analysis. Blockchain technology is employed to support the sharing and management of research analytics.
Akkure's top competitors include Unlearn, Virtonomy and ELEM Biotech.
Akkure offers AI Cancer Trial Finder and Genomics Platform.
Akkure has 2 investors. Key investors include Enterprise Ireland, and Digital Transformation Innovation Fund.